Atharv Ayu Research Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Atharv Ayu Research Pharma
Atharv Ayu Research Pharma Private Limited (AARPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 June 2020 (Four years and seven months 29 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priyaa Mishra and Satya Mishra serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100DL2020PTC365263
- Company No.
365263
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Atharv Ayu Research Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyaa Mishra  | Director | 26-Jun-2020 | Current |
| Satya Mishra | Director | 26-Jun-2020 | Current |
Financial Performance of Atharv Ayu Research Pharma.
Atharv Ayu Research Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Atharv Ayu Research Pharma?
Unlock access to Atharv Ayu Research Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Great Global Motels And Hospitalities Private LimitedPriyaa Mishra and Satya Mishra are mutual person
- Second Sight Vaastu Networks Private Limited
Priyaa Mishra and Satya Mishra are mutual person
- Elddaas International Private Limited
Satya Mishra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Atharv Ayu Research Pharma?
Atharv Ayu Research Pharma has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atharv Ayu Research Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atharv Ayu Research Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.